author-photo

Jennifa Gosling

University of California, San Francisco

21

Papers

5423

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Abstract 1595: Small molecule inhibition of the ubiquitin ligase CBL-B results in potent T and NK cell mediated anti-tumor response

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
98 NX-0255, a small molecule CBL-B inhibitor, expands and enhances tumor infiltrating lymphocytes (TIL) for use in adoptive cancer immunotherapy

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2696: Genetic and pharmacologic evaluation of the ubiquitin ligase CBL-B as a small-molecule, tumor immunotherapy target

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Inhibiteurs de cbl-b et leurs procédés d'utilisation

2019
Show All
- Source
- Cite
- Save
Citations (0)
Recepteur de chemokine

2000
Show All
- Source
- Cite
- Save
Citations (0)
Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice.

2000 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (145)
Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human

2000 European Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (132)
Exaggerated Hepatic Injury Due to Acetaminophen Challenge in Mice Lacking C-C Chemokine Receptor 2

2000 American Journal of Pathology
Show All
- Source
- Cite
- Save
Citations (119)
Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK

2000 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (187)
Enhanced myeloid progenitor cell cycling and apoptosis in mice lacking the chemokine receptor, CCR2

1999 Blood
Show All
- Source
- Cite
- Save
Citations (62)